Sergio ‘Armando’ Villalta, PhD
The Villalta laboratory is directed towards understanding how immune cells contribute to tissue injury and repair in degenerative and autoimmune
Magdalene J Seiler. Ph.D.
Retinal progenitor sheet transplantation and demonstration of vision improvement in models of retinal degeneration and ultimately in retinal degeneration patients
Matthew Rose, MD, PhD
We study the gene networks driving neuronal diversity during brainstem development to uncover why only specific subsets are differentially affected
Vladimir Kefalov, PhD.
Research Interests: Sensory Neurobiology, Photoreceptor physiology, Visual cycle and dark adaptation, Photoreceptor degeneration, Gene-independent therapy for visual disorders We are
Munjal Acharya, PhD
Our laboratory focuses on neurobiological mechanisms and regenerative medicine approaches to treat cancer and cancer therapy-related cognitive impairments (CRCI). We
Krzysztof (Kris) Palczewski, PhD
Gene augmentation therapy for correcting mutations in the RPE65 gene is the first FDA-approved gene therapy for any genetically inherited disease. There
Shahrdad Lotfipour, PhD
Research objectives are to understand the mechanisms mediating addictive disorders. Special interest is on how gut, genes, brain, and behavior
Leslie M. Thompson, PhD
Huntington’s disease (HD) is a devastating, inherited neurological disorder that causes psychiatric, cognitive and movement deficits.The Thompson laboratory is actively
Vivek Swarup, PhD
Our lab uses multi-omic approaches to understand molecular mechanism of neurodegenerative diseases like Alzheimer’s disease and Fronto-temporal dementia (FTD). We
Daniele Piomelli, PhD
My lab studies the neurobiology and pharmacology of the endocannabinoids and other bioactive lipids. Our approach combines molecular and cellular